The split screen is horrifying. On one side, a White House whose policy is in turns strident, revisionist, and then…
Two years ago, two days of protests were enough to force Georgia’s government into an embarrassing U-turn. It had tried…
At first whiff, it sounds repulsive: sniff the essence of an ancient corpse. But researchers who indulged their curiosity in…
Investor Insight Cardiol Therapeutics is positioned with a late-stage lead asset, multiple orphan indications, strong clinical proof-of-concept data, and a…